Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.
about
Academic, Foundation, and Industry Collaboration in Finding New Therapies.Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia.Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells
P2860
Correlation Among Hypoglycemia, Glycemic Variability, and C-Peptide Preservation After Alefacept Therapy in Patients with Type 1 Diabetes Mellitus: Analysis of Data from the Immune Tolerance Network T1DAL Trial.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Correlation Among Hypoglycemia ...... Tolerance Network T1DAL Trial.
@ast
Correlation Among Hypoglycemia ...... Tolerance Network T1DAL Trial.
@en
type
label
Correlation Among Hypoglycemia ...... Tolerance Network T1DAL Trial.
@ast
Correlation Among Hypoglycemia ...... Tolerance Network T1DAL Trial.
@en
prefLabel
Correlation Among Hypoglycemia ...... Tolerance Network T1DAL Trial.
@ast
Correlation Among Hypoglycemia ...... Tolerance Network T1DAL Trial.
@en
P2093
P2860
P921
P1476
Correlation Among Hypoglycemia ...... Tolerance Network T1DAL Trial
@en
P2093
Ashley Pinckney
Carol L Soppe
Lynette Keyes-Elstein
Mario R Ehlers
Mark R Rigby
P2860
P304
P356
10.1016/J.CLINTHERA.2016.04.032
P407
P577
2016-05-18T00:00:00Z